Pilot and Feasibility Program
Developing the next generation of polycystic kidney disease (PKD) investigators is crucial if continued progress is to be made in understanding and optimally treating PKD. The Pilot and Feasibility Program within the Mayo Translational Polycystic Kidney Disease (PKD) Center at Mayo Clinic provides investigators with funding to obtain preliminary data that can be used to support future extramural grant applications, especially National Institutes of Health (NIH) R01 applications.
The 2012 application period is closed.
The Pilot and Feasibility Program provides funding for up to four outstanding proposals a cycle. Each project receives funding of up to $40,000 a year for two years.
Three general categories of Mayo Clinic investigators are eligible for funding:
All applicants must have faculty appointments and be independent investigators. Funding can't be used for training purposes.
There are two phases to the application process:
Candidates will also meet with MTPC core directors.
Review process and criteria
The Pilot and Feasibility Program Scientific Review Committee oversees the review process and reviews letters of intent and invited full proposals. The committee is chaired by Nicholas F. LaRusso, M.D., director of the Pilot and Feasibility Program, and includes members of the Executive Committee, the chairs of the Internal Advisory Committee and External Advisory Committee, and ad hoc senior investigators with relevant scientific expertise.
Invited full proposals are scored (using the NIH scoring system of 1-9) based on:
After review by the Scientific Review Committee, the top-ranked applicants are asked to present their projects to the MTPC External Advisory Committee during its annual meeting.
Submit all material and questions to:
Vicente E. Torres, M.D., Ph.D.
Nicholas F. LaRusso, M.D.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.